New potential therapy targets in acute myeloid leukaemia

被引：0
|
作者：
Gallo, A.
Bund, D.
Mindnich, R.
Buhmann, R.
Schmetzer, H.
Adamski, J.
Kolb, H.
机构：
[1] GSF, Natl Res Ctr Environm & Hlth, Inst Mol Immunol, Munich, Germany
[2] GSF, Natl Res Ctr Environm & Hlth, Inst Expt Genet, Munich, Germany
[3] Univ Munich, Klinikum Grosshadern, Dept Hematopoet Transplantat, D-8000 Munich, Germany
来源：
EXPERIMENTAL HEMATOLOGY | 2007年 / 35卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [21] Immune Gene Therapy for Acute Myeloid Leukaemia
    Farzaneh, Farzin
    Chan, Lucas
    Hardwick, Nicola
    Ingram, Wendy
    Mufti, Ghulam
    Aloysius, Mark
    Robins, Adrian
    Habib, Nagy
    Bhalla, Joti
    Eremin, Oleg
    Jun, Tye Gee
    Oppenheim, David
    Wells, James
    Cowled, Christopher
    Noble, Alistair
    HUMAN GENE THERAPY, 2010, 21 (09) : 1177 - 1178
  • [22] Therapy of older persons with acute myeloid leukaemia
    Krug, Utz
    Gale, Robert Peter
    Berdel, Wolfgang E.
    Mueller-Tidow, Carsten
    Stelljes, Matthias
    Metzeler, Klaus
    Sauerland, M. Cristina
    Hiddemann, Wolfgang
    Buechner, Thomas
    LEUKEMIA RESEARCH, 2017, 60 : 1 - 10
  • [23] Closing in on targeted therapy for acute myeloid leukaemia
    不详
    LANCET HAEMATOLOGY, 2019, 6 (01): : E1 - E1
  • [24] Updating conventional therapy: new treatments for cell quiescence in acute myeloid leukaemia
    Lainez-Gonzalez, Daniel
    Candil-Sanchez, Manuel
    Belen Alonso-Aguado, Ana
    Serrano-Lopez, Juana
    Manuel Alonso-Dominguez, Juan
    FEBS OPEN BIO, 2024, 14 : 15 - 15
  • [25] Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?
    Beatriz Sanchez-Correa
    Carmen Campos
    Alejandra Pera
    Juan M. Bergua
    Maria Jose Arcos
    Helena Bañas
    Javier G. Casado
    Sara Morgado
    Esther Duran
    Rafael Solana
    Raquel Tarazona
    Cancer Immunology, Immunotherapy, 2016, 65 : 453 - 463
  • [26] Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?
    Sanchez-Correa, Beatriz
    Campos, Carmen
    Pera, Alejandra
    Bergua, Juan M.
    Jose Arcos, Maria
    Banas, Helena
    Casado, Javier G.
    Morgado, Sara
    Duran, Esther
    Solana, Rafael
    Tarazona, Raquel
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (04) : 453 - 463
  • [27] Mechanisms associated with t(7;12) acute myeloid leukaemia: from genetics to potential treatment targets
    Ragusa, Denise
    Dijkhuis, Liza
    Pina, Cristina
    Tosi, Sabrina
    BIOSCIENCE REPORTS, 2023, 43 (01)
  • [28] New drugs in the treatment of acute myeloid leukaemia
    Kayser, S.
    Schlenk, R. F.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (02) : 75 - 79
  • [29] New and emerging therapies for acute myeloid leukaemia
    Davis, Julian R.
    Benjamin, David J.
    Jonas, Brian A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (08) : 1088 - 1095
  • [30] MicroRNAs: new players in acute myeloid leukaemia
    Havelange, V.
    Garzon, R.
    Croce, C. M.
    BRITISH JOURNAL OF CANCER, 2009, 101 (05) : 743 - 748
12345